# droxidopa

NDC: 63304-104
Generic name: droxidopa
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210218

FDA application: ANDA214384

## Active ingredients

- DROXIDOPA: 200 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-104"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-104
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51ef3096-4622-4f45-a180-ab0dc6d46df9